nodes	percent_of_prediction	percent_of_DWPC	metapath
Diethylstilbestrol—CYP19A1—polycystic ovary syndrome	0.618	1	CbGaD
Diethylstilbestrol—CYP19A1—follicular fluid—polycystic ovary syndrome	0.026	0.14	CbGeAlD
Diethylstilbestrol—CYP19A1—corpus luteum—polycystic ovary syndrome	0.015	0.0809	CbGeAlD
Diethylstilbestrol—ESR2—ovarian follicle—polycystic ovary syndrome	0.0149	0.0803	CbGeAlD
Diethylstilbestrol—CYP19A1—ovarian follicle—polycystic ovary syndrome	0.0117	0.0632	CbGeAlD
Diethylstilbestrol—ESR1—ovarian follicle—polycystic ovary syndrome	0.0102	0.055	CbGeAlD
Diethylstilbestrol—TTR—urine—polycystic ovary syndrome	0.00784	0.0422	CbGeAlD
Diethylstilbestrol—ESRRG—embryo—polycystic ovary syndrome	0.0059	0.0318	CbGeAlD
Diethylstilbestrol—ESRRG—adrenal cortex—polycystic ovary syndrome	0.00484	0.0261	CbGeAlD
Diethylstilbestrol—ESRRG—pituitary gland—polycystic ovary syndrome	0.00391	0.0211	CbGeAlD
Diethylstilbestrol—ESRRG—adrenal gland—polycystic ovary syndrome	0.00349	0.0188	CbGeAlD
Diethylstilbestrol—ESRRG—vagina—polycystic ovary syndrome	0.00324	0.0174	CbGeAlD
Diethylstilbestrol—CYP2C9—urine—polycystic ovary syndrome	0.00312	0.0168	CbGeAlD
Diethylstilbestrol—ESRRG—endocrine gland—polycystic ovary syndrome	0.00303	0.0163	CbGeAlD
Diethylstilbestrol—CYP2E1—urine—polycystic ovary syndrome	0.00296	0.0159	CbGeAlD
Diethylstilbestrol—TTR—embryo—polycystic ovary syndrome	0.00253	0.0137	CbGeAlD
Diethylstilbestrol—CYP3A4—urine—polycystic ovary syndrome	0.00238	0.0128	CbGeAlD
Diethylstilbestrol—Ritodrine—ADRB2—polycystic ovary syndrome	0.00198	0.632	CrCbGaD
Diethylstilbestrol—TTR—pituitary gland—polycystic ovary syndrome	0.00168	0.00904	CbGeAlD
Diethylstilbestrol—AOX1—adrenal cortex—polycystic ovary syndrome	0.00159	0.00856	CbGeAlD
Diethylstilbestrol—COMT—adrenal cortex—polycystic ovary syndrome	0.00157	0.00848	CbGeAlD
Diethylstilbestrol—ESR2—endometrium—polycystic ovary syndrome	0.00147	0.00794	CbGeAlD
Diethylstilbestrol—AOX1—endometrium—polycystic ovary syndrome	0.00142	0.00764	CbGeAlD
Diethylstilbestrol—COMT—endometrium—polycystic ovary syndrome	0.00141	0.00757	CbGeAlD
Diethylstilbestrol—ESR1—embryo—polycystic ovary syndrome	0.00138	0.00743	CbGeAlD
Diethylstilbestrol—ESR2—uterus—polycystic ovary syndrome	0.00136	0.00732	CbGeAlD
Diethylstilbestrol—CYP2A6—adipose tissue—polycystic ovary syndrome	0.00134	0.00719	CbGeAlD
Diethylstilbestrol—ESR2—pituitary gland—polycystic ovary syndrome	0.00133	0.00719	CbGeAlD
Diethylstilbestrol—AOX1—uterus—polycystic ovary syndrome	0.00131	0.00704	CbGeAlD
Diethylstilbestrol—TTR—endocrine gland—polycystic ovary syndrome	0.0013	0.007	CbGeAlD
Diethylstilbestrol—COMT—uterus—polycystic ovary syndrome	0.00129	0.00698	CbGeAlD
Diethylstilbestrol—AOX1—pituitary gland—polycystic ovary syndrome	0.00128	0.00692	CbGeAlD
Diethylstilbestrol—AOX1—adipose tissue—polycystic ovary syndrome	0.00128	0.00689	CbGeAlD
Diethylstilbestrol—COMT—pituitary gland—polycystic ovary syndrome	0.00127	0.00685	CbGeAlD
Diethylstilbestrol—COMT—adipose tissue—polycystic ovary syndrome	0.00127	0.00682	CbGeAlD
Diethylstilbestrol—ESR2—adrenal gland—polycystic ovary syndrome	0.00119	0.00642	CbGeAlD
Diethylstilbestrol—CYP19A1—endometrium—polycystic ovary syndrome	0.00116	0.00626	CbGeAlD
Diethylstilbestrol—AOX1—adrenal gland—polycystic ovary syndrome	0.00115	0.00618	CbGeAlD
Diethylstilbestrol—COMT—adrenal gland—polycystic ovary syndrome	0.00114	0.00612	CbGeAlD
Diethylstilbestrol—ESR2—female gonad—polycystic ovary syndrome	0.00111	0.00599	CbGeAlD
Diethylstilbestrol—CYP2A6—vagina—polycystic ovary syndrome	0.00111	0.00598	CbGeAlD
Diethylstilbestrol—ESR2—vagina—polycystic ovary syndrome	0.0011	0.00595	CbGeAlD
Diethylstilbestrol—CYP19A1—uterus—polycystic ovary syndrome	0.00107	0.00577	CbGeAlD
Diethylstilbestrol—AOX1—female gonad—polycystic ovary syndrome	0.00107	0.00576	CbGeAlD
Diethylstilbestrol—AOX1—vagina—polycystic ovary syndrome	0.00106	0.00573	CbGeAlD
Diethylstilbestrol—COMT—female gonad—polycystic ovary syndrome	0.00106	0.00571	CbGeAlD
Diethylstilbestrol—COMT—vagina—polycystic ovary syndrome	0.00105	0.00567	CbGeAlD
Diethylstilbestrol—CYP19A1—adipose tissue—polycystic ovary syndrome	0.00105	0.00564	CbGeAlD
Diethylstilbestrol—ESR2—endocrine gland—polycystic ovary syndrome	0.00103	0.00557	CbGeAlD
Diethylstilbestrol—ESR1—endometrium—polycystic ovary syndrome	0.00101	0.00544	CbGeAlD
Diethylstilbestrol—AOX1—endocrine gland—polycystic ovary syndrome	0.000995	0.00536	CbGeAlD
Diethylstilbestrol—COMT—endocrine gland—polycystic ovary syndrome	0.000985	0.00531	CbGeAlD
Diethylstilbestrol—CYP19A1—adrenal gland—polycystic ovary syndrome	0.000939	0.00506	CbGeAlD
Diethylstilbestrol—ESR1—uterus—polycystic ovary syndrome	0.00093	0.00501	CbGeAlD
Diethylstilbestrol—ESR1—pituitary gland—polycystic ovary syndrome	0.000914	0.00492	CbGeAlD
Diethylstilbestrol—ESR1—adipose tissue—polycystic ovary syndrome	0.00091	0.0049	CbGeAlD
Diethylstilbestrol—ABCG2—adrenal cortex—polycystic ovary syndrome	0.000906	0.00488	CbGeAlD
Diethylstilbestrol—CYP19A1—female gonad—polycystic ovary syndrome	0.000876	0.00472	CbGeAlD
Diethylstilbestrol—CYP2C8—endometrium—polycystic ovary syndrome	0.000832	0.00448	CbGeAlD
Diethylstilbestrol—ESR1—adrenal gland—polycystic ovary syndrome	0.000816	0.0044	CbGeAlD
Diethylstilbestrol—CYP19A1—endocrine gland—polycystic ovary syndrome	0.000814	0.00439	CbGeAlD
Diethylstilbestrol—ABCG2—endometrium—polycystic ovary syndrome	0.000809	0.00436	CbGeAlD
Diethylstilbestrol—ESR1—female gonad—polycystic ovary syndrome	0.000761	0.0041	CbGeAlD
Diethylstilbestrol—ESR1—vagina—polycystic ovary syndrome	0.000756	0.00407	CbGeAlD
Diethylstilbestrol—CYP2C8—pituitary gland—polycystic ovary syndrome	0.000753	0.00405	CbGeAlD
Diethylstilbestrol—ABCG2—uterus—polycystic ovary syndrome	0.000745	0.00401	CbGeAlD
Diethylstilbestrol—ABCG2—pituitary gland—polycystic ovary syndrome	0.000732	0.00394	CbGeAlD
Diethylstilbestrol—ABCG2—adipose tissue—polycystic ovary syndrome	0.000729	0.00393	CbGeAlD
Diethylstilbestrol—ESR1—endocrine gland—polycystic ovary syndrome	0.000708	0.00381	CbGeAlD
Diethylstilbestrol—Tamoxifen—CYP19A1—polycystic ovary syndrome	0.000663	0.212	CrCbGaD
Diethylstilbestrol—ABCG2—adrenal gland—polycystic ovary syndrome	0.000654	0.00352	CbGeAlD
Diethylstilbestrol—CYP2C8—vagina—polycystic ovary syndrome	0.000623	0.00336	CbGeAlD
Diethylstilbestrol—ABCG2—female gonad—polycystic ovary syndrome	0.000609	0.00328	CbGeAlD
Diethylstilbestrol—ABCG2—vagina—polycystic ovary syndrome	0.000606	0.00326	CbGeAlD
Diethylstilbestrol—CYP2C8—endocrine gland—polycystic ovary syndrome	0.000583	0.00314	CbGeAlD
Diethylstilbestrol—CYP2E1—adrenal gland—polycystic ovary syndrome	0.000566	0.00305	CbGeAlD
Diethylstilbestrol—ABCB1—embryo—polycystic ovary syndrome	0.000545	0.00294	CbGeAlD
Diethylstilbestrol—CYP2C9—endocrine gland—polycystic ovary syndrome	0.000518	0.00279	CbGeAlD
Diethylstilbestrol—CYP2E1—endocrine gland—polycystic ovary syndrome	0.000491	0.00264	CbGeAlD
Diethylstilbestrol—Tamoxifen—CYP1A1—polycystic ovary syndrome	0.000488	0.156	CrCbGaD
Diethylstilbestrol—ABCB1—adrenal cortex—polycystic ovary syndrome	0.000447	0.00241	CbGeAlD
Diethylstilbestrol—ABCB1—endometrium—polycystic ovary syndrome	0.000399	0.00215	CbGeAlD
Diethylstilbestrol—CYP3A4—endocrine gland—polycystic ovary syndrome	0.000395	0.00213	CbGeAlD
Diethylstilbestrol—ABCB1—uterus—polycystic ovary syndrome	0.000367	0.00198	CbGeAlD
Diethylstilbestrol—ABCB1—pituitary gland—polycystic ovary syndrome	0.000361	0.00194	CbGeAlD
Diethylstilbestrol—ABCB1—adipose tissue—polycystic ovary syndrome	0.000359	0.00194	CbGeAlD
Diethylstilbestrol—ABCB1—adrenal gland—polycystic ovary syndrome	0.000322	0.00174	CbGeAlD
Diethylstilbestrol—ABCB1—female gonad—polycystic ovary syndrome	0.000301	0.00162	CbGeAlD
Diethylstilbestrol—ABCB1—vagina—polycystic ovary syndrome	0.000299	0.00161	CbGeAlD
Diethylstilbestrol—ABCB1—endocrine gland—polycystic ovary syndrome	0.00028	0.00151	CbGeAlD
Diethylstilbestrol—CYP2C9—Metabolism—TEAD2—polycystic ovary syndrome	2.75e-05	0.000142	CbGpPWpGaD
Diethylstilbestrol—CYP2C9—Metabolism—AKR1C2—polycystic ovary syndrome	2.75e-05	0.000142	CbGpPWpGaD
Diethylstilbestrol—ESR1—Signaling Pathways—LHB—polycystic ovary syndrome	2.73e-05	0.000141	CbGpPWpGaD
Diethylstilbestrol—ESR1—Generic Transcription Pathway—SERPINE1—polycystic ovary syndrome	2.72e-05	0.00014	CbGpPWpGaD
Diethylstilbestrol—ABCG2—Metabolism—RRM2—polycystic ovary syndrome	2.7e-05	0.000139	CbGpPWpGaD
Diethylstilbestrol—COMT—Metabolism—MTHFR—polycystic ovary syndrome	2.69e-05	0.000139	CbGpPWpGaD
Diethylstilbestrol—CYP2C8—Metabolism—SRD5A1—polycystic ovary syndrome	2.68e-05	0.000138	CbGpPWpGaD
Diethylstilbestrol—ESR1—Signaling Pathways—GNRH1—polycystic ovary syndrome	2.67e-05	0.000138	CbGpPWpGaD
Diethylstilbestrol—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	2.66e-05	0.000137	CbGpPWpGaD
Diethylstilbestrol—CYP19A1—Metabolism—AKR1C3—polycystic ovary syndrome	2.66e-05	0.000137	CbGpPWpGaD
Diethylstilbestrol—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	2.64e-05	0.000136	CbGpPWpGaD
Diethylstilbestrol—CYP2E1—Metabolism—HMMR—polycystic ovary syndrome	2.64e-05	0.000136	CbGpPWpGaD
Diethylstilbestrol—AOX1—Disease—SERPINE1—polycystic ovary syndrome	2.63e-05	0.000136	CbGpPWpGaD
Diethylstilbestrol—ABCB1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	2.62e-05	0.000135	CbGpPWpGaD
Diethylstilbestrol—CYP19A1—Metabolism—CYP17A1—polycystic ovary syndrome	2.62e-05	0.000135	CbGpPWpGaD
Diethylstilbestrol—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	2.6e-05	0.000134	CbGpPWpGaD
Diethylstilbestrol—ABCG2—Metabolism—YAP1—polycystic ovary syndrome	2.6e-05	0.000134	CbGpPWpGaD
Diethylstilbestrol—ESR2—Gene Expression—SERPINE1—polycystic ovary syndrome	2.6e-05	0.000134	CbGpPWpGaD
Diethylstilbestrol—ESR1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	2.59e-05	0.000134	CbGpPWpGaD
Diethylstilbestrol—ESR1—Signaling Pathways—SCT—polycystic ovary syndrome	2.56e-05	0.000132	CbGpPWpGaD
Diethylstilbestrol—CYP2C8—Metabolism—STAR—polycystic ovary syndrome	2.56e-05	0.000132	CbGpPWpGaD
Diethylstilbestrol—CYP2A6—Metabolism—SULT2A1—polycystic ovary syndrome	2.53e-05	0.000131	CbGpPWpGaD
Diethylstilbestrol—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	2.53e-05	0.000131	CbGpPWpGaD
Diethylstilbestrol—CYP2E1—Metabolism—HSD3B1—polycystic ovary syndrome	2.52e-05	0.00013	CbGpPWpGaD
Diethylstilbestrol—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	2.51e-05	0.000129	CbGpPWpGaD
Diethylstilbestrol—ABCG2—Metabolism—NAMPT—polycystic ovary syndrome	2.5e-05	0.000129	CbGpPWpGaD
Diethylstilbestrol—ABCG2—Metabolism—CYP11A1—polycystic ovary syndrome	2.47e-05	0.000127	CbGpPWpGaD
Diethylstilbestrol—ABCB1—Metabolism—PNPLA2—polycystic ovary syndrome	2.47e-05	0.000127	CbGpPWpGaD
Diethylstilbestrol—TTR—Signaling Pathways—IRS1—polycystic ovary syndrome	2.46e-05	0.000127	CbGpPWpGaD
Diethylstilbestrol—CYP2A6—Metabolism—RRM2—polycystic ovary syndrome	2.45e-05	0.000127	CbGpPWpGaD
Diethylstilbestrol—ESR1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	2.44e-05	0.000126	CbGpPWpGaD
Diethylstilbestrol—AOX1—Metabolism—PPARG—polycystic ovary syndrome	2.44e-05	0.000126	CbGpPWpGaD
Diethylstilbestrol—ABCB1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	2.44e-05	0.000126	CbGpPWpGaD
Diethylstilbestrol—AOX1—Metabolism—POMC—polycystic ovary syndrome	2.41e-05	0.000124	CbGpPWpGaD
Diethylstilbestrol—ESR1—Signaling Pathways—FGF18—polycystic ovary syndrome	2.4e-05	0.000124	CbGpPWpGaD
Diethylstilbestrol—AOX1—Metabolism—INS—polycystic ovary syndrome	2.4e-05	0.000124	CbGpPWpGaD
Diethylstilbestrol—ESR1—Signaling Pathways—RBP4—polycystic ovary syndrome	2.38e-05	0.000123	CbGpPWpGaD
Diethylstilbestrol—TTR—Signaling Pathways—POMC—polycystic ovary syndrome	2.37e-05	0.000122	CbGpPWpGaD
Diethylstilbestrol—CYP2A6—Metabolism—YAP1—polycystic ovary syndrome	2.36e-05	0.000122	CbGpPWpGaD
Diethylstilbestrol—TTR—Signaling Pathways—INS—polycystic ovary syndrome	2.36e-05	0.000122	CbGpPWpGaD
Diethylstilbestrol—ABCB1—Metabolism—SRD5A1—polycystic ovary syndrome	2.34e-05	0.000121	CbGpPWpGaD
Diethylstilbestrol—ABCG2—Metabolism—AKR1C3—polycystic ovary syndrome	2.33e-05	0.00012	CbGpPWpGaD
Diethylstilbestrol—ESR1—Gene Expression—AR—polycystic ovary syndrome	2.32e-05	0.00012	CbGpPWpGaD
Diethylstilbestrol—CYP2C9—Metabolism—PNPLA2—polycystic ovary syndrome	2.3e-05	0.000119	CbGpPWpGaD
Diethylstilbestrol—CYP2E1—Metabolism—LHB—polycystic ovary syndrome	2.3e-05	0.000119	CbGpPWpGaD
Diethylstilbestrol—ABCG2—Metabolism—CYP17A1—polycystic ovary syndrome	2.3e-05	0.000118	CbGpPWpGaD
Diethylstilbestrol—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	2.29e-05	0.000118	CbGpPWpGaD
Diethylstilbestrol—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	2.29e-05	0.000118	CbGpPWpGaD
Diethylstilbestrol—CYP2C8—Metabolism—HMMR—polycystic ovary syndrome	2.28e-05	0.000118	CbGpPWpGaD
Diethylstilbestrol—TTR—Signaling Pathways—IGF1—polycystic ovary syndrome	2.28e-05	0.000118	CbGpPWpGaD
Diethylstilbestrol—TTR—Signaling Pathways—AKT2—polycystic ovary syndrome	2.28e-05	0.000118	CbGpPWpGaD
Diethylstilbestrol—CYP2A6—Metabolism—NAMPT—polycystic ovary syndrome	2.27e-05	0.000117	CbGpPWpGaD
Diethylstilbestrol—CYP19A1—Metabolism—TH—polycystic ovary syndrome	2.27e-05	0.000117	CbGpPWpGaD
Diethylstilbestrol—CYP2E1—Metabolism—HSD3B2—polycystic ovary syndrome	2.24e-05	0.000116	CbGpPWpGaD
Diethylstilbestrol—CYP2A6—Metabolism—CYP11A1—polycystic ovary syndrome	2.24e-05	0.000116	CbGpPWpGaD
Diethylstilbestrol—ABCB1—Metabolism—STAR—polycystic ovary syndrome	2.23e-05	0.000115	CbGpPWpGaD
Diethylstilbestrol—ABCB1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	2.23e-05	0.000115	CbGpPWpGaD
Diethylstilbestrol—ESR1—Signaling Pathways—YAP1—polycystic ovary syndrome	2.22e-05	0.000115	CbGpPWpGaD
Diethylstilbestrol—CYP19A1—Metabolism—SLC2A4—polycystic ovary syndrome	2.2e-05	0.000114	CbGpPWpGaD
Diethylstilbestrol—ESR1—Signaling Pathways—GAB1—polycystic ovary syndrome	2.19e-05	0.000113	CbGpPWpGaD
Diethylstilbestrol—CYP2C9—Metabolism—SRD5A1—polycystic ovary syndrome	2.18e-05	0.000113	CbGpPWpGaD
Diethylstilbestrol—COMT—Metabolism—PPARG—polycystic ovary syndrome	2.18e-05	0.000112	CbGpPWpGaD
Diethylstilbestrol—CYP2C8—Metabolism—HSD3B1—polycystic ovary syndrome	2.18e-05	0.000112	CbGpPWpGaD
Diethylstilbestrol—CYP2E1—Metabolism—AKR1C1—polycystic ovary syndrome	2.17e-05	0.000112	CbGpPWpGaD
Diethylstilbestrol—TTR—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.16e-05	0.000112	CbGpPWpGaD
Diethylstilbestrol—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	2.15e-05	0.000111	CbGpPWpGaD
Diethylstilbestrol—COMT—Metabolism—POMC—polycystic ovary syndrome	2.15e-05	0.000111	CbGpPWpGaD
Diethylstilbestrol—COMT—Metabolism—INS—polycystic ovary syndrome	2.14e-05	0.00011	CbGpPWpGaD
Diethylstilbestrol—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	2.13e-05	0.00011	CbGpPWpGaD
Diethylstilbestrol—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	2.13e-05	0.00011	CbGpPWpGaD
Diethylstilbestrol—CYP2A6—Metabolism—AKR1C3—polycystic ovary syndrome	2.12e-05	0.000109	CbGpPWpGaD
Diethylstilbestrol—ESR1—Signaling Pathways—INSR—polycystic ovary syndrome	2.1e-05	0.000108	CbGpPWpGaD
Diethylstilbestrol—CYP2A6—Metabolism—CYP17A1—polycystic ovary syndrome	2.09e-05	0.000108	CbGpPWpGaD
Diethylstilbestrol—CYP2C9—Metabolism—STAR—polycystic ovary syndrome	2.08e-05	0.000108	CbGpPWpGaD
Diethylstilbestrol—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	2.06e-05	0.000106	CbGpPWpGaD
Diethylstilbestrol—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	2.04e-05	0.000105	CbGpPWpGaD
Diethylstilbestrol—ESR1—Gene Expression—NCOR1—polycystic ovary syndrome	2.03e-05	0.000105	CbGpPWpGaD
Diethylstilbestrol—CYP2E1—Metabolism—SULT2A1—polycystic ovary syndrome	2e-05	0.000103	CbGpPWpGaD
Diethylstilbestrol—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	1.99e-05	0.000103	CbGpPWpGaD
Diethylstilbestrol—ESR1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	1.99e-05	0.000103	CbGpPWpGaD
Diethylstilbestrol—ABCB1—Metabolism—HMMR—polycystic ovary syndrome	1.99e-05	0.000103	CbGpPWpGaD
Diethylstilbestrol—ABCG2—Metabolism—TH—polycystic ovary syndrome	1.99e-05	0.000102	CbGpPWpGaD
Diethylstilbestrol—CYP2C8—Metabolism—LHB—polycystic ovary syndrome	1.99e-05	0.000102	CbGpPWpGaD
Diethylstilbestrol—ESR1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	1.96e-05	0.000101	CbGpPWpGaD
Diethylstilbestrol—ESR1—Signaling Pathways—PGR—polycystic ovary syndrome	1.94e-05	0.0001	CbGpPWpGaD
Diethylstilbestrol—CYP2C8—Metabolism—HSD3B2—polycystic ovary syndrome	1.94e-05	0.0001	CbGpPWpGaD
Diethylstilbestrol—CYP2E1—Metabolism—RRM2—polycystic ovary syndrome	1.94e-05	0.0001	CbGpPWpGaD
Diethylstilbestrol—ABCG2—Metabolism—SLC2A4—polycystic ovary syndrome	1.93e-05	9.97e-05	CbGpPWpGaD
Diethylstilbestrol—ABCB1—Metabolism—HSD3B1—polycystic ovary syndrome	1.9e-05	9.79e-05	CbGpPWpGaD
Diethylstilbestrol—CYP2C8—Metabolism—AKR1C1—polycystic ovary syndrome	1.88e-05	9.7e-05	CbGpPWpGaD
Diethylstilbestrol—ESR1—Gene Expression—NR3C1—polycystic ovary syndrome	1.88e-05	9.69e-05	CbGpPWpGaD
Diethylstilbestrol—ABCB1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	1.87e-05	9.66e-05	CbGpPWpGaD
Diethylstilbestrol—CYP2E1—Metabolism—YAP1—polycystic ovary syndrome	1.87e-05	9.64e-05	CbGpPWpGaD
Diethylstilbestrol—CYP2C9—Metabolism—HMMR—polycystic ovary syndrome	1.86e-05	9.58e-05	CbGpPWpGaD
Diethylstilbestrol—CYP19A1—Metabolism—GNAS—polycystic ovary syndrome	1.85e-05	9.55e-05	CbGpPWpGaD
Diethylstilbestrol—ABCG2—Metabolism—CYP19A1—polycystic ovary syndrome	1.82e-05	9.37e-05	CbGpPWpGaD
Diethylstilbestrol—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	1.81e-05	9.36e-05	CbGpPWpGaD
Diethylstilbestrol—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	1.81e-05	9.36e-05	CbGpPWpGaD
Diethylstilbestrol—ESR1—Signaling Pathways—GHRL—polycystic ovary syndrome	1.8e-05	9.31e-05	CbGpPWpGaD
Diethylstilbestrol—ESR1—Signaling Pathways—PLAT—polycystic ovary syndrome	1.8e-05	9.31e-05	CbGpPWpGaD
Diethylstilbestrol—CYP2A6—Metabolism—TH—polycystic ovary syndrome	1.8e-05	9.31e-05	CbGpPWpGaD
Diethylstilbestrol—CYP2E1—Metabolism—NAMPT—polycystic ovary syndrome	1.79e-05	9.26e-05	CbGpPWpGaD
Diethylstilbestrol—CYP2E1—Metabolism—CYP11A1—polycystic ovary syndrome	1.77e-05	9.15e-05	CbGpPWpGaD
Diethylstilbestrol—CYP2C9—Metabolism—HSD3B1—polycystic ovary syndrome	1.77e-05	9.14e-05	CbGpPWpGaD
Diethylstilbestrol—CYP19A1—Metabolism—NCOR1—polycystic ovary syndrome	1.76e-05	9.1e-05	CbGpPWpGaD
Diethylstilbestrol—CYP2A6—Metabolism—SLC2A4—polycystic ovary syndrome	1.76e-05	9.06e-05	CbGpPWpGaD
Diethylstilbestrol—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	1.75e-05	9.04e-05	CbGpPWpGaD
Diethylstilbestrol—ABCB1—Metabolism—LHB—polycystic ovary syndrome	1.73e-05	8.92e-05	CbGpPWpGaD
Diethylstilbestrol—CYP2C8—Metabolism—SULT2A1—polycystic ovary syndrome	1.73e-05	8.92e-05	CbGpPWpGaD
Diethylstilbestrol—ESR1—Signaling Pathways—ATF1—polycystic ovary syndrome	1.72e-05	8.88e-05	CbGpPWpGaD
Diethylstilbestrol—ABCB1—Metabolism—HSD3B2—polycystic ovary syndrome	1.69e-05	8.72e-05	CbGpPWpGaD
Diethylstilbestrol—ESR1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.68e-05	8.66e-05	CbGpPWpGaD
Diethylstilbestrol—CYP2C8—Metabolism—RRM2—polycystic ovary syndrome	1.68e-05	8.64e-05	CbGpPWpGaD
Diethylstilbestrol—CYP2E1—Metabolism—AKR1C3—polycystic ovary syndrome	1.67e-05	8.64e-05	CbGpPWpGaD
Diethylstilbestrol—CYP19A1—Metabolism—CYP1A1—polycystic ovary syndrome	1.67e-05	8.62e-05	CbGpPWpGaD
Diethylstilbestrol—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	1.66e-05	8.57e-05	CbGpPWpGaD
Diethylstilbestrol—CYP2A6—Metabolism—CYP19A1—polycystic ovary syndrome	1.65e-05	8.51e-05	CbGpPWpGaD
Diethylstilbestrol—CYP2E1—Metabolism—CYP17A1—polycystic ovary syndrome	1.65e-05	8.5e-05	CbGpPWpGaD
Diethylstilbestrol—ABCB1—Metabolism—AKR1C1—polycystic ovary syndrome	1.64e-05	8.45e-05	CbGpPWpGaD
Diethylstilbestrol—ABCG2—Metabolism—GNAS—polycystic ovary syndrome	1.62e-05	8.37e-05	CbGpPWpGaD
Diethylstilbestrol—CYP2C9—Metabolism—LHB—polycystic ovary syndrome	1.62e-05	8.34e-05	CbGpPWpGaD
Diethylstilbestrol—CYP2C8—Metabolism—YAP1—polycystic ovary syndrome	1.61e-05	8.33e-05	CbGpPWpGaD
Diethylstilbestrol—ESR1—Signaling Pathways—NGFR—polycystic ovary syndrome	1.59e-05	8.2e-05	CbGpPWpGaD
Diethylstilbestrol—CYP2C9—Metabolism—HSD3B2—polycystic ovary syndrome	1.58e-05	8.15e-05	CbGpPWpGaD
Diethylstilbestrol—ESR1—Signaling Pathways—PRL—polycystic ovary syndrome	1.57e-05	8.13e-05	CbGpPWpGaD
Diethylstilbestrol—CYP19A1—Metabolism—MTHFR—polycystic ovary syndrome	1.56e-05	8.04e-05	CbGpPWpGaD
Diethylstilbestrol—CYP2C8—Metabolism—NAMPT—polycystic ovary syndrome	1.55e-05	8e-05	CbGpPWpGaD
Diethylstilbestrol—ABCG2—Metabolism—NCOR1—polycystic ovary syndrome	1.54e-05	7.97e-05	CbGpPWpGaD
Diethylstilbestrol—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.54e-05	7.96e-05	CbGpPWpGaD
Diethylstilbestrol—CYP2C8—Metabolism—CYP11A1—polycystic ovary syndrome	1.53e-05	7.91e-05	CbGpPWpGaD
Diethylstilbestrol—CYP2C9—Metabolism—AKR1C1—polycystic ovary syndrome	1.53e-05	7.89e-05	CbGpPWpGaD
Diethylstilbestrol—CYP2C8—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1.52e-05	7.85e-05	CbGpPWpGaD
Diethylstilbestrol—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	1.52e-05	7.84e-05	CbGpPWpGaD
Diethylstilbestrol—ABCB1—Metabolism—SULT2A1—polycystic ovary syndrome	1.51e-05	7.78e-05	CbGpPWpGaD
Diethylstilbestrol—ESR1—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.49e-05	7.71e-05	CbGpPWpGaD
Diethylstilbestrol—TTR—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.49e-05	7.68e-05	CbGpPWpGaD
Diethylstilbestrol—CYP2A6—Metabolism—GNAS—polycystic ovary syndrome	1.47e-05	7.6e-05	CbGpPWpGaD
Diethylstilbestrol—TTR—Disease—IL6—polycystic ovary syndrome	1.47e-05	7.59e-05	CbGpPWpGaD
Diethylstilbestrol—ABCG2—Metabolism—CYP1A1—polycystic ovary syndrome	1.46e-05	7.55e-05	CbGpPWpGaD
Diethylstilbestrol—ABCB1—Metabolism—RRM2—polycystic ovary syndrome	1.46e-05	7.53e-05	CbGpPWpGaD
Diethylstilbestrol—ESR1—Gene Expression—PPARG—polycystic ovary syndrome	1.45e-05	7.5e-05	CbGpPWpGaD
Diethylstilbestrol—CYP2C8—Metabolism—AKR1C3—polycystic ovary syndrome	1.45e-05	7.47e-05	CbGpPWpGaD
Diethylstilbestrol—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	1.44e-05	7.43e-05	CbGpPWpGaD
Diethylstilbestrol—CYP2E1—Metabolism—TH—polycystic ovary syndrome	1.43e-05	7.36e-05	CbGpPWpGaD
Diethylstilbestrol—CYP2C8—Metabolism—CYP17A1—polycystic ovary syndrome	1.42e-05	7.35e-05	CbGpPWpGaD
Diethylstilbestrol—CYP2C9—Metabolism—SULT2A1—polycystic ovary syndrome	1.41e-05	7.26e-05	CbGpPWpGaD
Diethylstilbestrol—ABCB1—Metabolism—YAP1—polycystic ovary syndrome	1.41e-05	7.26e-05	CbGpPWpGaD
Diethylstilbestrol—CYP2A6—Metabolism—NCOR1—polycystic ovary syndrome	1.4e-05	7.24e-05	CbGpPWpGaD
Diethylstilbestrol—CYP2E1—Metabolism—SLC2A4—polycystic ovary syndrome	1.39e-05	7.16e-05	CbGpPWpGaD
Diethylstilbestrol—ESR1—Signaling Pathways—GNAS—polycystic ovary syndrome	1.39e-05	7.15e-05	CbGpPWpGaD
Diethylstilbestrol—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	1.37e-05	7.09e-05	CbGpPWpGaD
Diethylstilbestrol—ABCG2—Metabolism—MTHFR—polycystic ovary syndrome	1.36e-05	7.04e-05	CbGpPWpGaD
Diethylstilbestrol—CYP2C9—Metabolism—RRM2—polycystic ovary syndrome	1.36e-05	7.03e-05	CbGpPWpGaD
Diethylstilbestrol—ABCB1—Metabolism—NAMPT—polycystic ovary syndrome	1.35e-05	6.97e-05	CbGpPWpGaD
Diethylstilbestrol—ABCB1—Metabolism—CYP11A1—polycystic ovary syndrome	1.33e-05	6.89e-05	CbGpPWpGaD
Diethylstilbestrol—CYP2A6—Metabolism—CYP1A1—polycystic ovary syndrome	1.33e-05	6.86e-05	CbGpPWpGaD
Diethylstilbestrol—ESR1—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.32e-05	6.81e-05	CbGpPWpGaD
Diethylstilbestrol—CYP2C9—Metabolism—YAP1—polycystic ovary syndrome	1.31e-05	6.78e-05	CbGpPWpGaD
Diethylstilbestrol—ESR1—Gene Expression—SERPINE1—polycystic ovary syndrome	1.31e-05	6.76e-05	CbGpPWpGaD
Diethylstilbestrol—CYP2E1—Metabolism—CYP19A1—polycystic ovary syndrome	1.3e-05	6.73e-05	CbGpPWpGaD
Diethylstilbestrol—ESR1—Signaling Pathways—NRG1—polycystic ovary syndrome	1.3e-05	6.68e-05	CbGpPWpGaD
Diethylstilbestrol—CYP19A1—Metabolism—PPARG—polycystic ovary syndrome	1.26e-05	6.52e-05	CbGpPWpGaD
Diethylstilbestrol—CYP2C9—Metabolism—NAMPT—polycystic ovary syndrome	1.26e-05	6.51e-05	CbGpPWpGaD
Diethylstilbestrol—ABCB1—Metabolism—AKR1C3—polycystic ovary syndrome	1.26e-05	6.5e-05	CbGpPWpGaD
Diethylstilbestrol—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.26e-05	6.48e-05	CbGpPWpGaD
Diethylstilbestrol—AOX1—Disease—IL6—polycystic ovary syndrome	1.25e-05	6.45e-05	CbGpPWpGaD
Diethylstilbestrol—CYP2C9—Metabolism—CYP11A1—polycystic ovary syndrome	1.25e-05	6.43e-05	CbGpPWpGaD
Diethylstilbestrol—CYP19A1—Metabolism—POMC—polycystic ovary syndrome	1.25e-05	6.43e-05	CbGpPWpGaD
Diethylstilbestrol—ABCB1—Metabolism—CYP17A1—polycystic ovary syndrome	1.24e-05	6.4e-05	CbGpPWpGaD
Diethylstilbestrol—CYP2A6—Metabolism—MTHFR—polycystic ovary syndrome	1.24e-05	6.4e-05	CbGpPWpGaD
Diethylstilbestrol—CYP19A1—Metabolism—INS—polycystic ovary syndrome	1.24e-05	6.39e-05	CbGpPWpGaD
Diethylstilbestrol—CYP2C9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1.24e-05	6.39e-05	CbGpPWpGaD
Diethylstilbestrol—CYP2C8—Metabolism—TH—polycystic ovary syndrome	1.23e-05	6.36e-05	CbGpPWpGaD
Diethylstilbestrol—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	1.22e-05	6.32e-05	CbGpPWpGaD
Diethylstilbestrol—CYP2C8—Metabolism—SLC2A4—polycystic ovary syndrome	1.2e-05	6.19e-05	CbGpPWpGaD
Diethylstilbestrol—CYP2C9—Metabolism—AKR1C3—polycystic ovary syndrome	1.18e-05	6.08e-05	CbGpPWpGaD
Diethylstilbestrol—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	1.17e-05	6.03e-05	CbGpPWpGaD
Diethylstilbestrol—CYP2E1—Metabolism—GNAS—polycystic ovary syndrome	1.16e-05	6.01e-05	CbGpPWpGaD
Diethylstilbestrol—CYP2C9—Metabolism—CYP17A1—polycystic ovary syndrome	1.16e-05	5.98e-05	CbGpPWpGaD
Diethylstilbestrol—CYP2C8—Metabolism—CYP19A1—polycystic ovary syndrome	1.13e-05	5.82e-05	CbGpPWpGaD
Diethylstilbestrol—ESR1—Signaling Pathways—IRS2—polycystic ovary syndrome	1.11e-05	5.72e-05	CbGpPWpGaD
Diethylstilbestrol—CYP2E1—Metabolism—NCOR1—polycystic ovary syndrome	1.11e-05	5.72e-05	CbGpPWpGaD
Diethylstilbestrol—ABCG2—Metabolism—PPARG—polycystic ovary syndrome	1.11e-05	5.71e-05	CbGpPWpGaD
Diethylstilbestrol—ABCG2—Metabolism—POMC—polycystic ovary syndrome	1.09e-05	5.63e-05	CbGpPWpGaD
Diethylstilbestrol—ESR1—Signaling Pathways—LEP—polycystic ovary syndrome	1.09e-05	5.6e-05	CbGpPWpGaD
Diethylstilbestrol—ABCG2—Metabolism—INS—polycystic ovary syndrome	1.09e-05	5.6e-05	CbGpPWpGaD
Diethylstilbestrol—ABCB1—Metabolism—TH—polycystic ovary syndrome	1.07e-05	5.54e-05	CbGpPWpGaD
Diethylstilbestrol—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	1.07e-05	5.5e-05	CbGpPWpGaD
Diethylstilbestrol—CYP2E1—Metabolism—CYP1A1—polycystic ovary syndrome	1.05e-05	5.42e-05	CbGpPWpGaD
Diethylstilbestrol—ABCB1—Metabolism—SLC2A4—polycystic ovary syndrome	1.04e-05	5.39e-05	CbGpPWpGaD
Diethylstilbestrol—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	1.04e-05	5.37e-05	CbGpPWpGaD
Diethylstilbestrol—TTR—Signaling Pathways—IL6—polycystic ovary syndrome	1.03e-05	5.31e-05	CbGpPWpGaD
Diethylstilbestrol—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	1.01e-05	5.21e-05	CbGpPWpGaD
Diethylstilbestrol—CYP2C8—Metabolism—GNAS—polycystic ovary syndrome	1.01e-05	5.19e-05	CbGpPWpGaD
Diethylstilbestrol—CYP2A6—Metabolism—PPARG—polycystic ovary syndrome	1.01e-05	5.19e-05	CbGpPWpGaD
Diethylstilbestrol—CYP2C9—Metabolism—TH—polycystic ovary syndrome	1e-05	5.18e-05	CbGpPWpGaD
Diethylstilbestrol—CYP2A6—Metabolism—POMC—polycystic ovary syndrome	9.92e-06	5.12e-05	CbGpPWpGaD
Diethylstilbestrol—CYP2A6—Metabolism—INS—polycystic ovary syndrome	9.86e-06	5.09e-05	CbGpPWpGaD
Diethylstilbestrol—ABCB1—Metabolism—CYP19A1—polycystic ovary syndrome	9.82e-06	5.07e-05	CbGpPWpGaD
Diethylstilbestrol—CYP2E1—Metabolism—MTHFR—polycystic ovary syndrome	9.8e-06	5.06e-05	CbGpPWpGaD
Diethylstilbestrol—CYP2C9—Metabolism—SLC2A4—polycystic ovary syndrome	9.76e-06	5.03e-05	CbGpPWpGaD
Diethylstilbestrol—ESR1—Signaling Pathways—IRS1—polycystic ovary syndrome	9.69e-06	5e-05	CbGpPWpGaD
Diethylstilbestrol—CYP2C8—Metabolism—NCOR1—polycystic ovary syndrome	9.58e-06	4.95e-05	CbGpPWpGaD
Diethylstilbestrol—ESR1—Signaling Pathways—POMC—polycystic ovary syndrome	9.33e-06	4.81e-05	CbGpPWpGaD
Diethylstilbestrol—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	9.28e-06	4.79e-05	CbGpPWpGaD
Diethylstilbestrol—ESR1—Signaling Pathways—INS—polycystic ovary syndrome	9.27e-06	4.79e-05	CbGpPWpGaD
Diethylstilbestrol—CYP2C9—Metabolism—CYP19A1—polycystic ovary syndrome	9.17e-06	4.73e-05	CbGpPWpGaD
Diethylstilbestrol—CYP2C8—Metabolism—CYP1A1—polycystic ovary syndrome	9.09e-06	4.69e-05	CbGpPWpGaD
Diethylstilbestrol—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	8.99e-06	4.64e-05	CbGpPWpGaD
Diethylstilbestrol—ESR1—Signaling Pathways—IGF1—polycystic ovary syndrome	8.97e-06	4.63e-05	CbGpPWpGaD
Diethylstilbestrol—ESR1—Signaling Pathways—AKT2—polycystic ovary syndrome	8.96e-06	4.63e-05	CbGpPWpGaD
Diethylstilbestrol—ABCB1—Metabolism—GNAS—polycystic ovary syndrome	8.76e-06	4.52e-05	CbGpPWpGaD
Diethylstilbestrol—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	8.67e-06	4.47e-05	CbGpPWpGaD
Diethylstilbestrol—ESR1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	8.52e-06	4.4e-05	CbGpPWpGaD
Diethylstilbestrol—CYP2C8—Metabolism—MTHFR—polycystic ovary syndrome	8.47e-06	4.37e-05	CbGpPWpGaD
Diethylstilbestrol—ABCB1—Metabolism—NCOR1—polycystic ovary syndrome	8.35e-06	4.31e-05	CbGpPWpGaD
Diethylstilbestrol—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	8.33e-06	4.3e-05	CbGpPWpGaD
Diethylstilbestrol—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	8.22e-06	4.24e-05	CbGpPWpGaD
Diethylstilbestrol—CYP2C9—Metabolism—GNAS—polycystic ovary syndrome	8.19e-06	4.23e-05	CbGpPWpGaD
Diethylstilbestrol—CYP2E1—Metabolism—PPARG—polycystic ovary syndrome	7.95e-06	4.1e-05	CbGpPWpGaD
Diethylstilbestrol—ABCB1—Metabolism—CYP1A1—polycystic ovary syndrome	7.92e-06	4.08e-05	CbGpPWpGaD
Diethylstilbestrol—CYP2E1—Metabolism—POMC—polycystic ovary syndrome	7.84e-06	4.04e-05	CbGpPWpGaD
Diethylstilbestrol—CYP2C9—Metabolism—NCOR1—polycystic ovary syndrome	7.8e-06	4.02e-05	CbGpPWpGaD
Diethylstilbestrol—CYP2E1—Metabolism—INS—polycystic ovary syndrome	7.79e-06	4.02e-05	CbGpPWpGaD
Diethylstilbestrol—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	7.77e-06	4.01e-05	CbGpPWpGaD
Diethylstilbestrol—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	7.64e-06	3.94e-05	CbGpPWpGaD
Diethylstilbestrol—CYP2C9—Metabolism—CYP1A1—polycystic ovary syndrome	7.39e-06	3.82e-05	CbGpPWpGaD
Diethylstilbestrol—ABCB1—Metabolism—MTHFR—polycystic ovary syndrome	7.38e-06	3.81e-05	CbGpPWpGaD
Diethylstilbestrol—CYP2C9—Metabolism—MTHFR—polycystic ovary syndrome	6.89e-06	3.56e-05	CbGpPWpGaD
Diethylstilbestrol—CYP2C8—Metabolism—PPARG—polycystic ovary syndrome	6.87e-06	3.54e-05	CbGpPWpGaD
Diethylstilbestrol—CYP2C8—Metabolism—POMC—polycystic ovary syndrome	6.77e-06	3.5e-05	CbGpPWpGaD
Diethylstilbestrol—CYP2C8—Metabolism—INS—polycystic ovary syndrome	6.74e-06	3.48e-05	CbGpPWpGaD
Diethylstilbestrol—CYP3A4—Metabolism—TH—polycystic ovary syndrome	6.61e-06	3.41e-05	CbGpPWpGaD
Diethylstilbestrol—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	6.43e-06	3.32e-05	CbGpPWpGaD
Diethylstilbestrol—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	6.05e-06	3.12e-05	CbGpPWpGaD
Diethylstilbestrol—ABCB1—Metabolism—PPARG—polycystic ovary syndrome	5.98e-06	3.09e-05	CbGpPWpGaD
Diethylstilbestrol—ABCB1—Metabolism—POMC—polycystic ovary syndrome	5.9e-06	3.05e-05	CbGpPWpGaD
Diethylstilbestrol—ABCB1—Metabolism—INS—polycystic ovary syndrome	5.87e-06	3.03e-05	CbGpPWpGaD
Diethylstilbestrol—ESR1—Signaling Pathways—VEGFA—polycystic ovary syndrome	5.86e-06	3.02e-05	CbGpPWpGaD
Diethylstilbestrol—CYP2C9—Metabolism—PPARG—polycystic ovary syndrome	5.59e-06	2.88e-05	CbGpPWpGaD
Diethylstilbestrol—CYP2C9—Metabolism—POMC—polycystic ovary syndrome	5.51e-06	2.84e-05	CbGpPWpGaD
Diethylstilbestrol—CYP2C9—Metabolism—INS—polycystic ovary syndrome	5.48e-06	2.83e-05	CbGpPWpGaD
Diethylstilbestrol—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	5.4e-06	2.79e-05	CbGpPWpGaD
Diethylstilbestrol—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	5.14e-06	2.65e-05	CbGpPWpGaD
Diethylstilbestrol—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	4.88e-06	2.52e-05	CbGpPWpGaD
Diethylstilbestrol—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	4.55e-06	2.35e-05	CbGpPWpGaD
Diethylstilbestrol—ESR1—Signaling Pathways—IL6—polycystic ovary syndrome	4.05e-06	2.09e-05	CbGpPWpGaD
Diethylstilbestrol—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	3.69e-06	1.9e-05	CbGpPWpGaD
Diethylstilbestrol—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	3.64e-06	1.88e-05	CbGpPWpGaD
Diethylstilbestrol—CYP3A4—Metabolism—INS—polycystic ovary syndrome	3.62e-06	1.87e-05	CbGpPWpGaD
